SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-276742
Filing Date
2015-08-04
Accepted
2015-08-04 17:02:01
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d50681d10q.htm 10-Q 510657
2 EX-31.1 d50681dex311.htm EX-31.1 8493
3 EX-31.2 d50681dex312.htm EX-31.2 8500
4 EX-32.1 d50681dex321.htm EX-32.1 5151
  Complete submission text file 0001193125-15-276742.txt   4184813

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnt-20150630.xml EX-101.INS 788724
6 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20150630.xsd EX-101.SCH 49938
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20150630_cal.xml EX-101.CAL 89544
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20150630_def.xml EX-101.DEF 178457
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20150630_lab.xml EX-101.LAB 404864
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20150630_pre.xml EX-101.PRE 306700
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 151026353
SIC: 2834 Pharmaceutical Preparations